Education
About Us
Working with TipRanks
Follow Us
MacLean Alexandra Insider Profile
4 Followers
MacLean Alexandra, CEO, Director at Avenue Therapeutics, holds 170.00K shares in Avenue Therapeutics (Ticker: ATXI).
MacLean Alexandra has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of MacLean Alexandra's holdings
Insider Roles
CEO, Director
Roles that MacLean Alexandra holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by MacLean Alexandra
MacLean Alexandra's Trading History
List of latest transactions for each holding click on a transaction to see MacLean Alexandra's performance on stock
You May Also Like
MacLean Alexandra insider profile FAQ
What is the percentage of profitable transactions made by MacLean Alexandra?
The percentage of profitable transactions made by MacLean Alexandra is ―.
What is the average return per transaction made by MacLean Alexandra?
The average return per transaction made by MacLean Alexandra is ―.
What stocks does MacLean Alexandra hold?
MacLean Alexandra holds: ATXI stocks.
What was MacLean Alexandra’s latest transaction?
MacLean Alexandra latest transaction was an Uninformative Buy of ―.
What was MacLean Alexandra's most profitable transaction?
MacLean Alexandra’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is MacLean Alexandra's role in Avenue Therapeutics?
MacLean Alexandra's role in Avenue Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.